Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

DARK SECRETS: 2 | Rare Historical Photos

Insurance Stocks Moving In Thursday's Intraday Session

According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session.

Here's How Much You Would Have Made Owning Marsh & McLennan Stock In The Last 15 Years

Here's How Much You Would Have Made Owning Marsh & McLennan Stock In The Last 15 Years

Marsh & McLennan (NYSE:MMC) has outperformed the market over the past 15 years by 4.99% on an annualized basis producing an average annual return of 11.19%. Currently, Marsh & McLennan has a market capitalization of $77.50 billion.

Looking Into Marsh & McLennan's Recent Short Interest

Looking Into Marsh & McLennan's Recent Short Interest

Marsh & McLennan's (NYSE:MMC) short percent of float has risen 23.61% since its last report. The company recently reported that it has 4.45 million shares sold short, which is 0.89% of all regular shares that are available for trading.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Here's How Much You Would Have Made Owning Marsh & McLennan Stock In The Last 10 Years

Marsh & McLennan (NYSE:MMC) has outperformed the market over the past 10 years by 6.09% on an annualized basis producing an average annual return of 16.75%. Currently, Marsh & McLennan has a market capitalization of $73.88 billion.

Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2022

Analyst Ratings for Marsh & McLennan

Over the past 3 months, 8 analysts have published their opinion on Marsh & McLennan (NYSE:MMC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2022

inkl

Read news from The Economist, FT, and more,
with one subscription

Analyst Ratings for Marsh & McLennan

Analyst Ratings for Marsh & McLennan

Within the last quarter, Marsh & McLennan (NYSE:MMC) has observed the following analyst ratings:

$100 Invested Marsh & McLennan Stock 5 Years Ago Would Be Worth This Much

$100 Invested Marsh & McLennan Stock 5 Years Ago Would Be Worth This Much

Marsh & McLennan (NYSE:MMC) has outperformed the market over the past 5 years by 6.21% on an annualized basis producing an average annual return of 18.7%. Currently, Marsh & McLennan has a market capitalization of $86.60 billion.

Insurance Stocks Moving In Thursday's Intraday Session

Insurance Stocks Moving In Thursday's Intraday Session

According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session.

Recap: Marsh & McLennan Q1 Earnings

Recap: Marsh & McLennan Q1 Earnings

Marsh & McLennan (NYSE:MMC) reported its Q1 earnings results on Thursday, April 21, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Marsh & McLennan's Earnings Outlook

Marsh & McLennan's Earnings Outlook

Marsh & McLennan (NYSE:MMC) is set to give its latest quarterly earnings report on Thursday, 2022-04-21. Here's what investors need to know before the announcement. Analysts estimate that Marsh & McLennan will report an earnings per share (EPS) of $2.14.

1 2

Organisations

Micron Technology

B of A Securities

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play